Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-000209 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 2, 2026 |
| Document Date | Dec 31, 2025 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,697
Total Value
$49,560.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's Title: Executive Vice President and Chief Medical Officer | Common Stock | โ | Dec 31, 2025 | Sale | 541 | $28.81 | $15,586.21 | 97,766 | Direct | โ | View Details | |
Reporting Person's Title: Executive Vice President and Chief Medical Officer | Common Stock | โ | Dec 31, 2025 | Sale | 1,156 | $29.39 | $33,974.03 | 96,610 | Direct | โ | View Details |